Ingredion (INGR) Cash & Equivalents (2016 - 2026)
Ingredion filings provide 17 years of Cash & Equivalents readings, the most recent being $1.0 billion for Q4 2025.
- On a quarterly basis, Cash & Equivalents rose 3.31% to $1.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 billion, a 3.31% increase, with the full-year FY2025 number at $1.0 billion, up 3.31% from a year prior.
- Cash & Equivalents hit $1.0 billion in Q4 2025 for Ingredion, up from $915.0 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $1.0 billion in Q4 2025 to a low of $236.0 million in Q4 2022.
- Median Cash & Equivalents over the past 5 years was $438.0 million (2024), compared with a mean of $552.9 million.
- Biggest five-year swings in Cash & Equivalents: tumbled 50.68% in 2021 and later surged 161.79% in 2024.
- Ingredion's Cash & Equivalents stood at $328.0 million in 2021, then dropped by 28.05% to $236.0 million in 2022, then surged by 69.92% to $401.0 million in 2023, then skyrocketed by 148.63% to $997.0 million in 2024, then rose by 3.31% to $1.0 billion in 2025.
- The last three reported values for Cash & Equivalents were $1.0 billion (Q4 2025), $915.0 million (Q3 2025), and $861.0 million (Q2 2025) per Business Quant data.